Heron Therapeutics (HRTX) Gross Profit Growth (3y) (2020 - 2026)
Heron Therapeutics (HRTX) Gross Profit Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
411.41% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.16% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Heron Therapeutics |
77.43 Mn |
47.47 Mn |
24.07 Mn |
23.56% |
| Date | Value |
|---|
| Mar 31, 2026 |
23.56% |
| Dec 31, 2025 |
19.20% |
| Sep 30, 2025 |
30.48% |
| Jun 30, 2025 |
33.64% |
| Mar 31, 2025 |
36.01% |
| Dec 31, 2024 |
43.77% |
| Sep 30, 2024 |
25.27% |
| Jun 30, 2024 |
47.67% |
| Mar 31, 2024 |
34.37% |
| Dec 31, 2023 |
29.49% |
| Sep 30, 2023 |
1.11% |
| Jun 30, 2023 |
-5.30% |
| Mar 31, 2023 |
-4.77% |
| Dec 31, 2022 |
-3.24% |
| Sep 30, 2022 |
-22.49% |
| Jun 30, 2022 |
-20.82% |
| Mar 31, 2022 |
-10.07% |
| Dec 31, 2021 |
-56.33% |
| Sep 30, 2021 |
-0.91% |
| Jun 30, 2021 |
-13.04% |
